Walleye Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
+23,311
New +$260K ﹤0.01% 3348
2026
Q1
Sell
-184,966
Closed -$1.84M 4328
2025
Q4
$1.84M Buy
184,966
+150,297
+434% +$1.44M 0.01% 1943
2025
Q3
$310K Buy
34,669
+24,080
+227% +$223K ﹤0.01% 2987
2025
Q2
$99.9K Buy
+10,589
New +$93.4K ﹤0.01% 3772
2024
Q2
Sell
-122,023
Closed -$1.4M 5530
2024
Q1
$1.4M Sell
122,023
-1,275
-1% -$10.8K ﹤0.01% 2262
2023
Q4
$899K Buy
+123,298
New +$972K ﹤0.01% 2442
2022
Q2
Sell
-23,557
Closed -$378K 2318
2022
Q1
$378K Buy
+23,557
New +$424K 0.01% 1164

Other funds holding AHCO

Walleye Capital's AHCO Position: Q2 2026 in Review

Walleye Capital opened a new position in AdaptHealth (AHCO) in Q2 2026: 23,311 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #3348 among its holdings. This is a return to the name: Walleye Capital previously reported a position in AHCO as recently as Q4 2025.

Walleye Capital first reported a position in AHCO in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.84M in Q4 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Walleye Capital held 23,311 shares of AdaptHealth worth $243K as of Q2 2026.
  • AdaptHealth was a new Walleye Capital position in Q2 2026.
  • AdaptHealth made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3348 holding.
  • Walleye Capital first reported a position in AdaptHealth in Q1 2022 and has held it in 7 quarters since.
  • Walleye Capital's AdaptHealth position peaked at $1.84M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.